Airlift Bioreactors Market Size & Share, by Product (Internal Airlift Loop Bioreactor, External Airlift loop Bioreactor); Material (Stainless Steel, Glass); Capacity (5L,7L,10L,30L); Usage (Single Use, Reusable); End User (Biopharmaceutical Companies, CRO/CDMO, Research & Development Companies) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 5765
  • Published Date: Feb 29, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024-2036

Airlift Bioreactors Market size is expected to reach USD 7.01 Billion by the end of 2036, growing at a CAGR of 6% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of airlift bioreactors was over USD 2.5 Billion. The market for airlift bioreactors is anticipated to rise at a faster rate due to the rising need for customized medications leading to the growth of the pharmaceutical industry. The Congressional Budget Office reports that the pharmaceutical industry invested USD 83 billion in research and development in 2019. In addition, it is anticipated that India's pharmaceutical sector will generate USD 130 billion by 2030 and USD 65 billion by 2024. Furthermore, Canada ranks eighth in the world for pharmaceutical sales, accounting for 2.2% of the global market. As the pharmaceutical business expands, so too does the market for airlift bioreactors. 

The anticipated surge in the airlift bioreactors market over the forecast period can be attributed to advancements in healthcare technology. Growing output of various biochemicals and heightened biochemical research activities are expected to present profitable growth prospects for the biochemical industry.


Airlift Bioreactors Market
Get more information on this report: Request Free Sample PDF

Airlift Bioreactors Sector: Growth Drivers and Challenges

Growth Drivers

  • Rising Demand for Biopharmaceutical - The market for airlift bioreactors is expanding due to the growing need for biopharmaceuticals. The aging population, rising rates of chronic illnesses, and improvements in medical treatments are all contributing to the growing demand for biopharmaceuticals, which in turn is driving up production costs. Airlift bioreactors provide scalable and effective solutions for large-scale biopharmaceutical manufacturing, allowing producers to keep up with the increasing demand. When compared to conventional bioreactor systems, tors offer benefits such as increased oxygen transfer, greater mass transfer rates, and less shear stress on cells. The production methods for biopharmaceuticals are more productive and efficient as a result of these characteristics. In light of this, with the rising demand for biopharmaceuticals, the airlift bioreactors market is anticipated to grow. 
  • Expanding Biotechnology Industry - Bioprocessing equipment, such as bioreactors, is highly dependent on the biotechnology sector for several uses, including fermentation, protein expression, and cell culture. To support research, development, and production activities, there is a corresponding rise in demand for bioprocessing equipment as the biotechnology sector grows. Continuous innovation and technical breakthroughs are what define the biotechnology sector and result in the creation of innovative treatments, diagnostics, and industrial bioproducts. Airlift bioreactors, which offer a versatile platform for bioprocess development and optimization, are essential in facilitating these improvements due to their capacity to handle a broad variety of cell types and process conditions. The need for sophisticated bioprocessing machinery, such as airlift bioreactors, is growing as biotechnology research advances, propelling market expansion.
  • Technological Advancements- The market for airlift bioreactors is being positively impacted by technological developments in airlift bioreactors, which are continuously enhancing their performance, efficiency, and versatility. More dependable and effective airlift bioreactors have been created as a result of design and engineering advancements. Improved mass transfer, oxygenation, and mixing efficiency are the results of these developments, which also include creative reactor geometry, improved impeller designs, and improved mixing techniques. Improved design elements increase the commercial attractiveness of airlift bioreactors by making them more flexible and adaptable to a variety of bioprocessing applications. Improvements in sensor technology, such as the creation of sturdy and dependable sensors to track different process parameters, help to maximize the performance of airlift bioreactors.

Challenges

  • High Initial Investment Needed- Specialized engineering and design are needed for airlift bioreactors in order to maximize their effectiveness for certain uses. It takes a lot of research and development (R&D) costs, including prototype, testing, and iteration, to create dependable and efficient systems. It is frequently necessary to adapt and incorporate airlift bioreactors into already-existing production facilities or processes. To suit the particular needs of each application, the bioreactor's size, design, and control systems may need to be modified. Because customization is hard, it takes longer and costs more to implement, which makes it difficult for businesses to justify the investment—especially if they expect low production quantities or erratic demand. These expenses add to the expensive initial outlay and may put off prospective purchasers, particularly smaller businesses with constrained funds for research and development.
  • Regulatory Hurdles may Hinder Market Growth
  • Lack of Awareness Among the People Related to Airlift Bioreactors

Airlift Bioreactors Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

 6%

Base Year Market Size (2023)

  USD 2.5 Billion

Forecast Year Market Size (2036)

 USD 7.01 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Airlift Bioreactors Segmentation

Product (Internal Airlift Loop Bioreactor, External Airlift Loop Bioreactor)

Airlift bioreactors market in the internal airlift loop bioreactor segment is anticipated to hold the largest revenue share of 56% during the forecast period. Numerous industries have begun to use and pay attention to bioreactors. These bioreactors are well-liked and dominate the market because they provide special benefits. They offer effective mass transport of gases and nutrients as well as good liquid phase mixing. Because of their considerable scalability, internal airlift loop bioreactors can be easily adapted to various production scales. The market landscape is also influenced by recent developments, changing uses, and rising technology.

End-User (Biopharmaceutical Companies, CRO/CDMO, Research & Development Companies)

The biopharmaceutical companies segment of the airlift bioreactors market is expected to hold a share of 53% by the end of 2036. The demand for customized medicine, the rising incidence of chronic diseases, and innovative therapies have all contributed to the biopharmaceutical industry's recent significant rise. These businesses frequently need scalable manufacturing solutions to keep up with the demands of their expanding commercial production needs. For biopharmaceutical businesses looking to go from laboratory-scale to commercial-scale production, airlift bioreactors offer an appealing alternative due to their scalability and capacity to maintain stable hydrodynamic conditions during scale-up. Aside from this, airlift bioreactors help biopharmaceutical businesses achieve their goals by offering ideal conditions for cell development and product creation. These organizations place a high priority on protecting the integrity and purity of their goods.

Our in-depth analysis of the global airlift bioreactors market includes the following segments:

         Product

  • Internal Airlift Loop Bioreactor
  • External Airlift loop Bioreactor

         Capacity

  • 5L
  • 7L
  • 10L
  • 30L

         Material

  • Stainless Steel
  • Glass

          Usage

  • Single Use
  • Reusable

           End User

  • Biopharmaceutical Companies
  • CRO/CDMO
  • Research&Development Companies

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Airlift Bioreactors Industry - Regional Synopsis

North American Market Forecast

Airlift bioreactors market in the North America region is poised to account for the largest share of 30% during the foreseen period. Product launches regularly, biotechnology developments and other encouraging elements propel the industry in this region. The United States alone accounts for about one-third of the worldwide biopharmaceutical industry and leads in biopharmaceutical R&D, demonstrating the region's strong infrastructure for biopharmaceutical manufacturing. For instance; the Pharmaceutical Research and Manufacturers Association (PhRMA) estimates that more than any other industry in the United States in 2017, biopharmaceutical companies invested around USD 97 billion in research and development (R&D). These mostly foreign-owned companies invested roughly USD 20 billion in R&D in the same year. The adoption of airlift bioreactors is fueled by the substantial investments in the biotechnology and pharmaceutical sectors that this rich ecosystem draws.

APAC Market Statistics

APAC airlift bioreactors market is anticipated to hold the second-largest share of 22% during the forecast period. Its rise is driven by the increase in demand for bio-based products, which is especially evident in China given its emphasis on ethanol production. Improved mass transfer and increased oxygen transfer rates are two of the unique benefits that make airlift bioreactors a desirable option for bio-based manufacturing in the region. This crucial component is anticipated to fuel revenue growth in the Asia Pacific market, solidifying its standing as a major force behind the advancement of the sector.

Research Nester
Airlift Bioreactors Market Size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Airlift Bioreactors Landscape

top-features-companies
    • Kuhner Shaker
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Cellexus
    • Sartorius
    • Lonza
    • Electrolab Biotech
    • Shree Biocare
    • Rotech
    • Knik Technology
    • Solida Biotech
    • Zeta

In-the-news

In The News

  • Mar 2022- Cellexus partnered with Verder Liquids, a Castleford based company. By this move, companies aimed to offer pumps for acid/base pump that is included with its CellMaker Plus and Low Flow bioreactor systems. The CellMaker bioreactor system is used by researchers all over the world to cultivate cells in their labs for use in novel drug and vaccination trials.
     
  • Mar 2022- Zeta established a new subsidiary in Singapore so that Asian biotechnology and pharmaceutical businesses may take advantage of customer-specific services.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 5765
  • Published Date: Feb 29, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Growing biopharmaceutical industry, rising spending on R&D activities are the major factors driving the growth of the surgical monitor market.

The market size of Airlift Bioreactors is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2024-2036.

The major players in the market are Cellexus, Sartorius, Lonza, Electrolab Biotech, Shree Biocare, Rotech, Knik Technology, Solida Biotech, Zeta and others.

The internal airlift loop bioreactors segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North America region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Airlift Bioreactors Market Report Scope
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying